ARCHIVES

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

April 27, 2012

Advisory Groups: Nominations Sought For Director’s Consumer Liaision Group

June 13, 1997

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014

Funding Opporunities: Program Announcments

January 15, 1999

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012